Research Topics
Species | Jerome CouturierSummaryAffiliation: Institut Curie Country: France Publications
| Collaborators
|
Detail Information
Publications
[Diagnosis of HER2 gene amplification in breast carcinoma]J Couturier
Service de génétique oncologique, Institut Curie, 26, rue d Ulm, 75248 Paris Cedex 05, France
Pathol Biol (Paris) 56:375-9. 2008..Clusters of signals are characteristic of amplifications. The process designed for the assessment of HER2 is a model of strategies that will be used for the evaluation of markers involved in future targeted therapies...
Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinomaJ Couturier
Department of Genetics, Institut Curie, Section Médicale, Paris, France
Mod Pathol 13:1238-43. 2000..Thus, under standardized conditions, IHC is a reliable and economical test to assess the ERBB2 status in tumors. The use of FISH could be limited to the verification of the status of tumors displaying a weak membrane immunostaining...
[Genomic classification of renal cell tumors in adults]Jerome Couturier
Service de génétique oncologique, Institut Curie Hôpital, 26, rue d Ulm, 75248 Paris Cedex 05, France
Ann Pathol 28:402-8. 2008..2, and TFEB, in 6p21. So, molecular diagnosis, either by identification of specific translocations, or by genomic profiling, can be of valuable help for typing renal tumors when histological classification is difficult...
Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumorsFariba Nemati
Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, Paris, France
Clin Cancer Res 16:2352-62. 2010..The aim of this study was to develop and characterize a panel of human uveal melanoma xenografts transplanted into immunodeficient mice...
Accumulation of segmental alterations determines progression in neuroblastomaGudrun Schleiermacher
L Institut National de la Santé et de la Recherche Médicale U830, Institut Curie, 26 Rue d Ulm, 75248 Paris Cedex 05, France
J Clin Oncol 28:3122-30. 2010..We explored the role of segmental alterations in tumor progression and the possibility of evolution from indolent to aggressive genomic types...
Adult papillary renal tumor with oncocytic cells: clinicopathologic, immunohistochemical, and cytogenetic features of 10 casesMarine Lefevre
Department of Pathology, Tenon, Institut Curie, Paris, France
Am J Surg Pathol 29:1576-81. 2005..These results suggest that adult papillary renal tumors with oncocytic cells might be a distinct variant in the papillary renal cell carcinoma group...
A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancerJean Philippe Meyniel
Department of Translational Research, Institut Curie, 26 Rue d Ulm, 75248 Paris, Cedex 05, France
BMC Cancer 10:222. 2010..The purpose of the present work was to develop genomic and transcriptomic tools to further refine the pathological diagnosis of ovarian tumors after a previous history of breast cancer...
Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literaturePhilippe Camparo
HIA Val de Grace, Van Andel Research Institute, Paris, France
Am J Surg Pathol 32:656-70. 2008..Our results suggest that these differentially expressed genes may serve as novel diagnostic or prognostic markers...
Frequent genomic structural alterations at HPV insertion sites in cervical carcinomaMartine Peter
Department of Tumour Biology, Institut Curie, F 75248 Paris, France
J Pathol 221:320-30. 2010..Structural alterations of the host genome are frequently observed at the integration site of HPV DNA in cervical cancer and may act in oncogenesis...
MDM2 as a modifier gene in retinoblastomaLaurent Castera
Pharm D, Department of Oncogenetics, Institut Curie, Paris, France
J Natl Cancer Inst 102:1805-8. 2010....
Fine-needle aspiration as a diagnostic technique in 50 cases of primary Ewing sarcoma/peripheral neuroectodermal tumor. Institut Curie's experienceJerzy Klijanienko
Department of Tumor Biology, Institut Curie, Paris, France
Diagn Cytopathol 40:19-25. 2012..In conclusion, FNA assisted by genomic techniques is powerful methods to accurate diagnose ES/PNET...
Diagnostic and prognostic information obtained on fine-needle aspirates of primary neuroblastic tumors: Proposal for a cytology prognostic scoreJerzy Klijanienko
Department of Pathology, Institut Curie, Paris, France
Cancer Cytopathol 119:411-23. 2011..The use of cytological material for diagnosis and prognosis in patients with neuroblastic tumors is poorly described in the literature...
A deep intronic mutation in the RB1 gene leads to intronic sequence exonisationCatherine Dehainault
Service de génétique oncologique, Institut Curie, Paris, France
Eur J Hum Genet 15:473-7. 2007..This is the first report of a deep intronic mutation in RB1 and is a proof of concept that some undetected RB1 mutations should be investigated at the cDNA level, particularly in hereditary forms of retinoblastoma...
Overall genomic pattern is a predictor of outcome in neuroblastomaIsabelle Janoueix-Lerosey
INSERM U830, Laboratoire de Génétique et Biologie des Cancers, 26 Rue d Ulm, 75248 Paris Cedex 05, France
J Clin Oncol 27:1026-33. 2009..For a comprehensive overview of the genetic alterations of neuroblastoma, their association and clinical significance, we conducted a whole-genome DNA copy number analysis...
Clear-cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven casesJulien Adam
Department of Pathology, Hopital Necker Enfants Malades, AP HP, Paris Université Paris Descartes, Paris, France
Histopathology 58:1064-71. 2011..To report clinicopathological and genomic characteristics of (ccpRCC), a rare, recently characterized renal tumour entity...
Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastasesJulien Trolet
Department of Bioinformatics, Institut Curie, Paris, France
Invest Ophthalmol Vis Sci 50:2572-80. 2009..The purpose of this study was to analyze genomic profiles in a large series of ocular tumors and liver metastases and design a genome-based classifier for metastatic risk assessment...
High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patientsCecile Laurent
Institut Curie, Paris, France
Cancer Res 71:666-74. 2011..Our findings suggest that PTP4A3 or its cellular substrates could constitute attractive therapeutic targets to treat metastatic uveal melanomas...
High efficacy of combined rituximab and gemcitabine on Epstein-Barr virus-associated human B-cell lymphoma obtained after Hodgkin's xenograft in immunodeficient miceDidier Decaudin
Department of Clinical Hematology, Section de Recherche, Institut Curie, Paris, France
Anticancer Drugs 17:685-95. 2006..This result therefore indicates that combined rituximab and gemcitabine could be an alternative approach in patients with posttransplant lymphoproliferative disease...
In vivo efficacy of photodynamic therapy in three new xenograft models of human retinoblastomaIsabelle Aerts
INSERM U 612, Centre de Recherche, Institut Curie, 26 Rue d Ulm, 75 248 Paris cedex 05, France
Photodiagnosis Photodyn Ther 7:275-83. 2010..Photodynamic therapy represents a nonmutagenic therapeutic approach, and may reduce the incidence of secondary tumors. To study the in vivo efficacy of photodynamic therapy, human retinoblastoma xenografts were established in nude mice...
Genetic determinants of uveal melanomaJerome Couturier
Department of Genetics, Institut Curie Hôpital, Paris, France
Dev Ophthalmol 49:150-65. 2012..3, coding for a protein promoting cell migration, is highly overexpressed in class 2 tumors. The overall expression signature of class 2 tumors suggests they may originate from neuroectodermal stem cells...
The Bloom syndrome protein limits the lethality associated with RAD51 deficiencyKenza Lahkim Bennani-Belhaj
Institut Curie, Centre de Recherche, Centre Universitaire, Orsay, France
Mol Cancer Res 8:385-94. 2010..These findings provide insight into the molecular basis of some cancers possibly associated with variants of the RAD51 gene family...
Cyto-histological correlations in primary, recurrent and metastatic rhabdomyosarcoma: the institut Curie's experienceJerzy Klijanienko
Department of Tumor Biology, Institut Curie, Paris, France
Diagn Cytopathol 35:482-7. 2007..9% vs. 6.7%), mitotic figures (57.1% vs. 18.9%), and cyto-nuclear atypia (77.1% vs. 43.2%). Inversely, spindle-shaped cells were more frequently seen in nonalveolar versus alveolar RMSs (37.8% vs. 20.9%)...
Phyllodes tumors of the breast segregate in two groups according to genetic criteriaMarick Lae
Departement de Biologie des Tumeurs, Service de Pathologie, Institut Curie Hôpital, Paris, France
Mod Pathol 20:435-44. 2007..Helpful additional pathological criteria for differentiating the two genetic groups of phyllodes tumors are the nuclear size and the mitotic rate...
Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patientsMaura Campitelli
Department of Radiation Oncology, Institut Curie, Hospital, Paris, France
PLoS ONE 7:e43393. 2012..To determine whether the sequence of the cell-viral junction could be used in clinical practice as a specific marker of ctDNA, we analyzed a series of cervical cancer patient serums...
Fine-needle aspiration cytology combined with flow cytometry immunophenotyping is a rapid and accurate approach for the evaluation of suspicious superficial lymphoid lesionsClaire Mathiot
Hematology Laboratory, Department of Tumor Biology, Institut Curie, Paris, France
Diagn Cytopathol 34:472-8. 2006....
Three new BLM gene mutations associated with Bloom syndromeMounira Amor-Gueret
Institut Curie, Centre de Recherche, Orsay, France
Genet Test 12:257-61. 2008..All these mutations introduce a stop codon, and may therefore be considered to have deleterious biological effect. This approach should make it possible to identify new mutations and to correlate them with clinical information...
Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesisXavier Sastre-Garau
Department of Pathology, Institut Curie, Paris, France
J Pathol 218:48-56. 2009..This information will help the development of novel approaches for the assessment and therapy of MCC and biologically related tumours...
Genotype-phenotype correlations in hereditary familial retinoblastomaMelissa Taylor
Service d Oncologie Pediatrique, Institut Curie, Paris, France
Hum Mutat 28:284-93. 2007..Our analysis suggests in some cases the influence of modifier factors probably involved in mRNA level regulation and/or pRB pathway regulation...
Mucinous tubular and spindle cell carcinoma: a report of 15 cases and a review of the literatureSophie Ferlicot
Service d Anatomie Pathologique, Hopital de Bicetre, Paris, France
Virchows Arch 447:978-83. 2005..Further investigations are required to determine the frequency and true prognosis of these tumors, which are easily identifiable morphologically...
Role of chemotherapy resistance genes in outcome of neuroblastomaPatricia De Cremoux
Department of Tumor Biology, Institut Curie, 26 Rue d Ulm, Paris Cedex, France
Pediatr Blood Cancer 48:311-7. 2007..Most patients with localized disease usually have a favorable prognosis, but patients with advanced disease have a poor prognosis despite combination chemotherapy. Treatment failure may be attributable to resistance to cytotoxic drugs...
Five new cases of juvenile renal cell carcinoma with translocations involving Xp11.2: a cytogenetic and morphologic studyChristine Perot
Laboratoire de Cytogenetique, Hopital Saint Antoine, Paris, France
Cancer Genet Cytogenet 143:93-9. 2003..Renal cell carcinomas with translocations involving Xp11.2 form a specific entity characterized by subtle pathologic features and younger age of occurrence, especially for those with the t(X;17)...
Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancerL Arnould
Department of Pathology, Centre GF Leclerc, 1 rue Pr Marion, 21034 Dijon Cedex, France
Br J Cancer 88:1587-91. 2003..Our results allow us to think that, in many laboratories, CISH may also be an excellent method to calibrate the IHC procedures or, as a quality control test, to check regularly that the IHC signal is in agreement with the gene status...
Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentre GEFPICS studyA Vincent-Salomon
Institut Curie, Paris, France
Histopathology 42:337-47. 2003..This prompted us to perform a multicentric IHC calibration test to achieve a maximum accuracy of HER2-IHC compared with HER2-FISH taken as the reference method...
Quality assessment of genetic markers used for therapy stratificationI M Ambros
Children s Cancer Research Institute, Kinderspitalgasse 6, A 1090 Vienna, Austria
J Clin Oncol 21:2077-84. 2003..Materials and..
Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSFC Houdayer
Service de génétique oncologique, Institut Curie, Paris, France
Hum Mutat 23:193-202. 2004..Finally, considering the benefits to retinoblastoma patients, RB1 testing should be widely implemented in routine healthcare because our study clearly illustrates its feasibility...
Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breastX Sastre-Garau
Department of Pathology, CNRS UMR144, Institut Curie, Paris, France
Histopathology 45:142-7. 2004..Akt has been found to be involved in the HER-2/neu signal transduction pathway and Akt activation has been associated with increased cell size in various models...
Multiplex PCR/liquid chromatography assay for detection of gene rearrangements: application to RB1 geneC Dehainault
, , Institut Curie, Paris, France
Nucleic Acids Res 32:e139. 2004..MP/LC appears to be an easy, versatile, and cost-effective method, which is particularly relevant to denaturing HPLC (DHPLC) users since it broadens the spectrum of available applications on a DHPLC system...
Integration of viral sequences into the c-myc gene in two mammary adenocarcinomas induced by polyomavirus in athymic nude miceM Berebbi
CNRS ER 105, Villejuif, France
J Virol 69:5935-45. 1995..This deleted region in the episomal virus genome was systematically found integrated in chromosomal DNA, thus arguing for the importance of Py integration in the induction of mammary tumor...
HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?A Vincent-Salomon
Department of Tumor Biology, Institut Curie, Paris, France
Br J Cancer 96:654-9. 2007..Therefore, the efficiency of anti-HER2 adjuvant therapy could be evaluated, in a clinical trial, by sequential detection of HER2-positive micrometastatic cells within the bone marrow, before and after treatment...
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplificationG Schleiermacher
INSERM U830, Institut Curie, Paris, France
Br J Cancer 97:238-46. 2007..Further studies using higher-resolution CGH are needed to better characterise atypical genomic alterations...
hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entitiesF Bourdeaut
INSERM U509, Laboratoire de Pathologie Moléculaire des Cancers, 26 Rue d Ulm, 75248 Paris Cedex 05, France
J Pathol 211:323-30. 2007..The molecular investigation should be performed in infants when a rhabdoid predisposition syndrome is suspected...
A new member of the ETS family fused to EWS in Ewing tumorsM Peter
Laboratoire de Transfert, Institut Curie, Paris, France
Oncogene 14:1159-64. 1997..Following a scheme similar to previously described translocations in Ewing tumors, a t(2;22) chromosome translocation fuses the N-terminal domain of EWS to the ETS DNA binding domain of FEV...
In neuroblastic tumours, Schwann cells do not harbour the genetic alterations of neuroblasts but may nevertheless share the same clonal originF Bourdeaut
INSERM, U830, Section de Recherche, Unité de Génétique et Biologie des Cancers, Institut Curie, Paris, France
Oncogene 27:3066-71. 2008..However, in tumours with both stroma-rich and -poor components, our results suggest that cells from both areas share a common progenitor...
